Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 2,341–2,360 of 17,937 drug recalls

Drug Recall Terminated Historical recordClass II

succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6011-2

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated
July 17, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2010-2

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated
July 17, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

HYDROmorphone added to 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 100 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2010-3

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated
July 17, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL, 5000 mcg/100 mL, (50 mcg/mL), 100 mL Bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-5

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated
July 17, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 100 mL bag, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-4

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated
July 17, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2013-2

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated
July 17, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

vecuronium, 10 mg/10mL, (1 mg/mL), 10 mL syringe, Rx only, PARALYZING AGENT, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6012-1.

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated
July 17, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL, 1250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-7

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated
July 17, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C San Diego, CA 92126, NDC: 71286-2001-2

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated
July 17, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, 24 mEq K, Maintenance 8:1 non-enriched, Low Potassium, IV Bag, Total Volume = 300 mL, RX only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC 72196-0215-1

by Central Admixture Pharmacy Services, Inc.

Reason
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated
July 14, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, 24 mEq K, Maintenance 8:1, Low Potassium, IV Bag, total volume = 500 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0105-1

by Central Admixture Pharmacy Services, Inc.

Reason
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated
July 14, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, 20 mEq K, Maintenance 4:1, Low Potassium, IV Bag, total volume = 810 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0103-1

by Central Admixture Pharmacy Services, Inc.

Reason
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated
July 14, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, 108 mEq K, Induction 8:1, High Potassium, IV Bag, total volume = 500 mL, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0102-1

by Central Admixture Pharmacy Services, Inc.

Reason
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated
July 14, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, 100 mEq K, Induction 8:1, High Potassium / Low dextrose, IV Bag, total volume = 500 mL, RX Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0107-1

by Central Admixture Pharmacy Services, Inc.

Reason
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated
July 14, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION 122 mEq K, Modified St. Thomas Formula High Potassium, Total Volume = 1000 mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0209-1

by Central Admixture Pharmacy Services, Inc.

Reason
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated
July 14, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, LEESBURG CARDIOPLEGIA, IV Bag, Total Volume = 1030.2 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0218-1

by Central Admixture Pharmacy Services, Inc.

Reason
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated
July 14, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, 48 mEq K, Induction 4:1 in Ringer's, High Potassium, IV Bag, total volume = 522.8 mL, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0206-1

by Central Admixture Pharmacy Services, Inc.

Reason
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated
July 14, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, 15 mEq K, Reperfusate 4:1, low potassium, IV Bag, total volume = 477.5mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0008-1

by Central Admixture Pharmacy Services, Inc.

Reason
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated
July 14, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, 36 mEq K, Induction 4:1, High Potassium/Low tromethamine, IV Bag, total volume = 500 mL, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0101-1

by Central Admixture Pharmacy Services, Inc.

Reason
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated
July 14, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, HIGH K, Induction 4:1 Plasmalyte, High Potassium, IV Bag, total volume = 542 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0212-1

by Central Admixture Pharmacy Services, Inc.

Reason
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated
July 14, 2023
Reported by FDA
August 9, 2023
Distribution
Nationwide in the USA

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.